Schonfeld Strategic Advisors’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $267K | Buy |
161,951
+76,973
| +91% | +$127K | ﹤0.01% | 1628 |
|
|
2025
Q1 | $134K | Sell |
84,978
-91,680
| -52% | -$145K | ﹤0.01% | 1862 |
|
|
2024
Q4 | $592K | Buy |
176,658
+8,058
| +5% | +$27K | ﹤0.01% | 1266 |
|
|
2024
Q3 | $317K | Sell |
168,600
-47,623
| -22% | -$89.5K | ﹤0.01% | 1487 |
|
|
2024
Q2 | $426K | Sell |
216,223
-3,577
| -2% | -$7.05K | ﹤0.01% | 1425 |
|
|
2024
Q1 | $675K | Buy |
+219,800
| New | +$675K | ﹤0.01% | 1193 |
|
|
2021
Q2 | – | Sell |
-969
| Closed | -$119K | – | 2288 |
|
|
2021
Q1 | $119K | Sell |
969
-73
| -7% | -$8.97K | ﹤0.01% | 1569 |
|
|
2020
Q4 | $119K | Sell |
1,042
-2,037
| -66% | -$233K | ﹤0.01% | 1387 |
|
|
2020
Q3 | $368K | Sell |
3,079
-2,189
| -42% | -$262K | 0.01% | 977 |
|
|
2020
Q2 | $657K | Buy |
+5,268
| New | +$657K | 0.02% | 679 |
|
|
2018
Q4 | – | Sell |
-694
| Closed | -$493K | – | 1238 |
|
|
2018
Q3 | $493K | Hold |
694
| – | – | 0.02% | 579 |
|
|
2018
Q2 | $406K | Buy |
+694
| New | +$406K | 0.02% | 574 |
|